1. Derse PH (1969) U. S. Clearinghouse, Federal Science and Technology Information, P. B. Report 195153
2. Fricke WA (1990) Evaluation of the risk of hepatitis from clotting factor concentrates. In: Kasper CK (ed) Recent advances in hemophilia care. Alan R. Liss, New York, pp 161–166
3. Gomperts E (1988) Hemofil M: characteristics, pharmacokinetics, efficacy and safety. In: Roberts HR (ed) Biotechnology and the promise of pure factor VIII. Baxter Scientific, Brussels, pp 41–47
4. Gomperts E, De Biasi R, Hemofil M Study Group (1991) Antihemophilic factor isolated with monoclonal antibody. Proceedings of the XIX WFH. (in press)
5. Homburger F (1968) U. S. Clearinghouse Federal Science and Technology Information, P. B. Report 183027